Navigation Links
OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
Date:7/23/2012

SAN DIEGO, July 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced data from an interim analysis of two randomized Phase III clinical trials, HNBE-01 and HNBE-02, using electrochemotherapy to treat locally recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN). The data are being presented July 22-24 at the 8th International Conference on Head and Neck Cancer in Toronto, Canada. A link to the abstract can be found here: http://ahns.jnabstracts.com/Detail.aspx?ID=0778

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

In these studies, electrochemotherapy was compared against surgery for quality of life, safety, survival and local control at eight months, where local control is defined as destruction of the treated tumor without evidence of reappearance of the tumor at the treatment site. The data show OMS ElectroChemotherapy achieved the primary endpoint of preserving quality of life compared to surgery, and appears to be safe and comparable to surgery in achieving control in locally recurrent or second primary SCCHN. This therapy represents a viable alternative to potentially major surgical interventions for this patient population, where recurrent tumors in SCCHN usually have a poor prognosis with a local control rate of 40-50 percent and frequently associated loss of organ function.

Paul Goldfarb, M.D., Consulting Medical Director of OncoSec overseeing the Phase III studies, said, "Despite the early termination of this study, delayed interim analysis of these data clearly demonstrated there was equivalence in safety, local control at eight months and survival between electrochemotherapy and surge
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
6. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
7. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... FARUM, Denmark and ATLANTA ... July 31, 2015 the US Food and Drug Administration (FDA) ... Major Depressive Disorder in adult patients who have failed to ... episode. TMS is a non-invasive technique for stimulating neural tissue ... from Major Depressive Disorder. The procedure has been proven safe ...
(Date:8/28/2015)... August 28, 2015 The report "Eubiotics Market by ... Poultry, Ruminant, and Aquaculture), & by Region ( North ... Asia-Pacific , and Rest of the World) - Global ... market for Eubiotics was valued at USD 4.62 Billion in ... 2020, at a CAGR of 7.4% from 2015 to 2020. ...
(Date:8/28/2015)... SAN FRANCISCO , August 28, 2015 ... is expected to reach USD 49.12 billion by 2020, ... 2020, according to a new report by Grand View ... an estimated CAGR of 49.7% from 2014 to 2020. ... Growing aging population along with rising incidences of ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
... 6, 2011 Bayer HealthCare Pharmaceuticals Inc. today announced ... SYM ptomatic P rostate CA ncer) ... exclusively licensed from Algeta ASA, in patients with castration-resistant ... endpoint by significantly improving overall survival.  Based on a ...
... Eli Lilly and Company (NYSE: LLY ) ... ALIMTA® (pemetrexed for injection) in the continuation maintenance setting, ... time a patient is alive without their disease worsening, ... called advanced nonsquamous non-small cell lung cancer (NSCLC). ...
Cached Medicine Technology:Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 2Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 3New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 2New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 3New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 4New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 5New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 6New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening 7
(Date:8/31/2015)... ... 31, 2015 , ... NSF International, an independent global organization ... sciences and consumer goods industries, has recognized Clean Water Systems & Stores Inc ... Manganese Dioxide. , Developed by a team of scientists and industry experts NSF/ANSI ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... its physician related services by test marketing a doctor note service to be ... will be charged under $50 for each generated excuse, much less than the ...
(Date:8/30/2015)... Aliso Viejo, CA (PRWEB) , ... August 30, 2015 , ... ... for Final Cut Pro X. ProTrailer Party contains 30 styled and detailed presets, ... kinetic animations to reveal each title, these titles will help film makers save time ...
(Date:8/30/2015)... ... August 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, ... 3:00 p.m. EDT, http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ... from India. , With alerts on an uptick and a new final rule, having ...
(Date:8/30/2015)... ... August 30, 2015 , ... The ... that Partner Daniel M. Kotin was recently elected to membership in the American ... highest degree of peer recognition and outstanding professionalism. , ABOTA is an ...
Breaking Medicine News(10 mins):Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 3Health News:FCPX Effects Developer Releases ProTrailer Party for Final Cut Pro X 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3
... Smoke-Free in 90 Days, HARRISBURG, Pa., June 13 ... Clean Indoor Air Act, which will protect,Pennsylvanians from the ... most public places, including restaurants,workplaces and a portion of ... persistence of advocates and,legislators who refused to quit working ...
... sickened in the ongoing salmonella outbreak , , FRIDAY, June ... reported illnesses from salmonella-tainted tomatoes continued to climb, U.S. ... of the contamination. , The number of people sickened ... states, with 25 hospitalizations, health officials announced Thursday. Six ...
... Paris, France, Friday 13 June 2008: Certain cardiovascular disease (CVD) ... similar effect on an RA patient,s risk of experiencing myocardial ... today at EULAR 2008, the Annual Congress of the European ... researchers studied 10,870 RA patients for a median of 24 ...
... bioengineers and bioscientists at Rice University and Radboud University ... bone tissue by sprinkling stick-like nanoparticles throughout the porous ... is available online and slated to appear in the ... the burgeoning field of tissue engineering. The new discipline ...
... Award, MINNEAPOLIS, June 13 Minneapolis-based Courage ... its deadline,for nominations for its annual Jay and ... by Courage Center to people with disabilities who ... deadline is,Thursday, July 3, 2008., The Phillips ...
... Paris, France, Friday 13 June 2008: Two new initiatives ... patient participation were presented today at EULAR 2008, the ... Paris, France. , The RAID disease impact ... and validation of the EULAR patient-derived Rheumatoid Arthritis Impact ...
Cached Medicine News:Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 3Health News:Source of Contaminated Tomatoes Still Unknown: FDA 2Health News:Source of Contaminated Tomatoes Still Unknown: FDA 3Health News:Source of Contaminated Tomatoes Still Unknown: FDA 4Health News:Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events 2Health News:Nanoparticles aid bone growth 2Health News:Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3 2Health News:New insight into RA patient priorities and motivators for clinical trial involvement 2Health News:New insight into RA patient priorities and motivators for clinical trial involvement 3
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle....
10 mm wide tip....
9 mm wide tip. 35 mm from angle to tip....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: